Current Members

Anita Bandrowski, PhD, The Antibody Registery, and Center For Research In Biological Systems, University of California San Diego, La Jolla, CA (2015-present) 

Valina Dawson, PhD, Department of Neurology, The Johns Hopkins University School of Medicine, Baltimore, MD 21287 (2010-present)

Richard Krogsrud, PhD, Antibodies Incorporated, PO Box 1560, Davis, CA 95617 (2005-present)

Laurie Nadler, PhD, NIMH, Program Chief, Neuropharmacology Program, Bethesda, MD 20892 (2005-2008, 2015-present) 

Jeffrey L. Noebels, MD, PhD, Department of Neurology, Baylor College of Medicine, Houston, TX 77030 (2008-present)

Matthew Rasband, PhD, Department of Neuroscience, Baylor College of Medicine, Houston, TX 77030 (2010-present)

Kenneth J. Rhodes, PhD, Chief Scientific Officer, Yumanity Therapeutics, Cambridge, MA 02139 (2007-2010, 2015-present)

Randall Stewart, PhD, NINDS, Program Director for Channels, Synapses, and Circuits, Bethesda, MD 20892 (2005-present)

James S. Trimmer, PhD, Department of Neurobiology, Physiology and Behavior, University of California, Davis, CA 95616 (2005-present) 

James Wells, PhD. Depts of Pharmaceutical Chemistry and Cellular and Molecular Pharmacology, University of California, San Francisco, CA 94158 (2015-present) 

Many Thanks to Past Advisory Board Members

William A. Catterall, PhD, Department of Pharmacology, School of Medicine, University of Washington, Seattle, WA 98195 (2005-2010)

Edward G. Jones, Center for Neuroscience, University of California, Davis, CA 95616 (2005-2007)

Alex Kolodkin, Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD (2005-2007)

Gail Mandel, PhD, Vollum Institute, Oregon Health and Science University, Portland, OR 97239 (2009-2015)

Roland Newman, PhD, Tanabe Research Laboratories, USA, San Diego, CA 92121 (2010-2015)
  
Morgan Sheng, MBBS, PhD, Vice President, Neuroscience and Molecular Biology, Genentech, South San Francisco, CA 94080 (2005-2010)